Old Web
English
Sign In
Acemap
>
authorDetail
>
Michael A. Burgess
Michael A. Burgess
University of Texas MD Anderson Cancer Center
Pathology
Sarcoma
Medicine
Ifosfamide
Soft tissue sarcoma
4
Papers
241
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Quantitative real time-PCR of CD133 mRNA: A potential surrogate angiogenic marker of response for patients with metastatic sarcoma
2006
Journal of Clinical Oncology
E. H. Lin
Y. li
J. C. Trent
Sunil M. Patel
Michael A. Burgess
Dejka M. Steinert
Robert S. Benjamin
Donghui Li
Lei L. Chen
Show All
Source
Cite
Save
Citations (1)
A two-arm phase II study of temozolomide in patients with advanced gastrointestinal stromal tumors and other soft tissue sarcomas.
2003
Cancer
Jonathan C. Trent
R N Jennifer Beach
Michael A. Burgess
Nicholas Papadopolous
Lei L. Chen
Robert S. Benjamin
Shreyaskumar R. Patel
Show All
Source
Cite
Save
Citations (98)
Radiographic response to neoadjuvant chemotherapy is a predictor of local control and survival in soft tissue sarcomas
2002
Cancer
Funda Meric
Kenneth R. Hess
Datla G.K. Varma
Kelly K. Hunt
Peter W. T. Pisters
Kresimira M. Milas
Shreyaskumar R. Patel
Robert S. Benjamin
Carl Plager
Nicholas E. Papadopoulos
Michael A. Burgess
Raphael E. Pollock
Barry W. Feig
Show All
Source
Cite
Save
Citations (108)
Concurrent ifosfamide-based chemotherapy and irradiation analysis of treatment-related toxicity in 43 patients with sarcoma
2001
Cancer
Janice N. Cormier
Shreyaskumar R. Patel
Cynthia E. Herzog
Matthew T. Ballo
Michael A. Burgess
Barry W. Feig
Kelly K. Hunt
Richard B. Raney
Gunar K. Zagars
Robert S. Benjamin
Peter W. T. Pisters
Show All
Source
Cite
Save
Citations (34)
1